Abstract
Value of Minimal Residual Disease (MRD) Monitoring Using Real-Time Quantitative PCR in Patients with Acute Promyelocytic Leukemia (APL) Treated with ATRA, ATO, +/- GO
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have